AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Close
Create a link to this page
Copy and paste this link tag into your Web page or blog:
<a href="http://www.accessmylibrary.com/article-1G1-76659385/preclinical-and-clinical-advances.html" title="Facts and information about Preclinical And Clinical Advances To Headline At Conference.(Brief Article)">Preclinical And Clinical Advances To Headline At Conference.(Brief Article)</a>
Close
Set up an RSS feed that alerts you when new articles from Vaccine Weekly are available.
Frequently asked questions about RSS feeds
Preclinical And Clinical Advances To Headline At Conference.(Brief Article)
2001 JUL 25 - (NewsRx.com & NewsRx.net) --
Late-breaking advances in engineered antibodies research, in post-genomic high-throughput (HTP) antibody research, in development of novel targets/selection, as well as monoclonal antibody generation and preclinical and clinical advances will be the focus of the "Engineered Antibodies Accelerating Drug Discovery and Development Conference and Exposition" taking place in Philadelphia, Pennsylvania, on September 18-19, 2001.
The meeting will be divided into four discrete sections, of five to eight papers ...
Related articles from newspapers, magazines, journals, and more
For more facts and information, see all results
- Study data from University of Melbourne update knowledge of engineered...
- Newspaper article from: Blood Weekly March 12, 2009 700+ words
...plaques," scientists in Australia report (see also Engineered Antibodies). "The 4 kDa Abeta peptide (39-43 amino acids...Oxford OX2 6DP, England. Keywords: Australia, Engineered Antibodies, Alzheimer Disease, Amino Acids, Bioengineering...
- AVANIR Pharmaceuticals' Subsidiary, Xenerex Biosciences, Demonstrates...
- Press release article from: PR Newswire October 23, 2001 700+ words
...the data at the Strategic Research Institute's annual Engineered Antibodies Conference yesterday afternoon in Philadelphia. Dr...therapeutic products in the future." The conference, titled Engineered Antibodies Accelerating Drug Discovery and Development, was organized...
- Engineered Antibodies Conference & Exposition to be Held September 18-19 in...
- Press release article from: PR Newswire May 1, 2001 700+ words
...research community will be convening in Philadelphia on September 18-19 to attend, speak, and exhibit at "Engineered Antibodies Accelerating Drug Discovery & Development," announces Strategic Research Institute. The conference...
- Engineered Antibodies Conference to Feature Top Exhibiting Companies at...
- Press release article from: PR Newswire July 12, 2001 700+ words
...tier players in the development of antibody technologies, are several of the first exhibitors to attend "Engineered Antibodies Conference & Exposition" on Sept 18-19 in Philadelphia, PA, announces Strategic Research Institute...
- Engineered Antibodies Conference to be Represented by over a Hundred Leading...
- Press release article from: PR Newswire July 30, 2001 700+ words
...world industrial antibody community will be convening in Philadelphia, PA on September 18-19, to attend "Engineered Antibodies Conference & Exposition". The meeting is distinguished by the high quality presentations and recent...
- Cancer Therapeutic Leader Immunogen to Speak at Engineered Antibodies...
- Press release article from: PR Newswire July 24, 2001 700+ words
...amp; Abgenix, will take part in section one headlined Post Genomic Antibody R & D in September's "Engineered Antibodies Conference & Exposition" on Sept 18-19 in Philadelphia, PA, announces Strategic Research Institute...
- Antigen-Targeted Antibody-Based Therapies to Be Featured at Engineered...
- Press release article from: PR Newswire May 15, 2001 700+ words
...immunotherapeutic agents for the treatment of certain late-stage cancers will be featured on September 18-19 "Engineered Antibodies Accelerating Drug Discovery & Development" conference in Philadelphia, announces Strategic Research...
- Antigen-Targeted Antibody-Based Therapies to be Featured at Engineered...
- Press release article from: PR Newswire June 6, 2001 700+ words
...immunotherapeutic agents for the treatment of certain late-stage cancers will be featured on September 18-19 "Engineered Antibodies Accelerating Drug Discovery & Development" conference in Philadelphia, announces Strategic Research...